All Articles

As far-right protests loom, the Ahmadiyya Muslim Community's National Peace Symposium will convene global leaders to champion justice as the key to peace.

As 7.io expands, it champions crypto-native speed and fairness, but navigates a landscape fraught with regulatory risk and security challenges.

Nocpix enters the digital riflescope market with the NITE D70R, packing a 12MP sensor and integrated ballistics to challenge established industry leaders.

China's 'Dream Stream' at the Venice Biennale merges ancient philosophy with AI art, video games, and immersive installations in a stunning display.

As mobile phone bans clash with cyber insurance mandates, an innovative solution turns student laptops into security keys, setting a new global standard.

Wondrlab is investing $100M in WondrBridge, a venture building small, AI-powered innovation hubs that challenge traditional outsourcing models.

A breakthrough manufacturing process from JBD solves a key MicroLED bottleneck, promising to lower costs and finally make AR smart glasses a reality for all.

Pharma veteran Shyamakant Giri takes the helm at Apothecon Group, signaling an aggressive push into global regulated markets backed by Everstone Capital.

PFPFA's new Signature Centre at Ngee Ann City signals a shift in wealth management, blending personalized advisory with high-end retail real estate.

Despite hedging losses, the energy producer reaffirms its 2026 outlook, fueled by major production gains from its key Charlie Lake and Montney assets.

A former oil refinery is being transformed into the Northeast's largest film studio, a $1B project poised to make New Jersey a new Hollywood East.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

A new study finds a minimally invasive procedure provides greater short-term weight loss than a popular pill, reshaping the debate on obesity treatment.

The iconic American rib chain is back in China, but this is more than just a restaurant opening. It's a high-tech, high-stakes bet on the future.

Nubank's AI-first strategy drives record revenue and profitability in Mexico, but rising delinquencies test its advanced risk management models.

A Houston firm is set to make waves with a rare Modigliani drawing and a private Dalí painting, complete with personal letters from the artist.

The federal push for electrification faces backlash for ignoring propane's key role in rural and Northern Canada, raising fears of a costly transition.

As its CFO presents at a top NYC conference, Healios K.K. advances novel stem cell treatments for ARDS, stroke, and cancer into critical global trials.

Westaim posted a $33.4M Q1 loss, but strong early sales from its new annuity product suggest a long-term strategic transformation is taking root.